These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 29234087)

  • 1. Conformational Switch Regulates the DNA Cytosine Deaminase Activity of Human APOBEC3B.
    Shi K; Demir Ö; Carpenter MA; Wagner J; Kurahashi K; Harris RS; Amaro RE; Aihara H
    Sci Rep; 2017 Dec; 7(1):17415. PubMed ID: 29234087
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structural Analysis of the Active Site and DNA Binding of Human Cytidine Deaminase APOBEC3B.
    Hou S; Silvas TV; Leidner F; Nalivaika EA; Matsuo H; Kurt Yilmaz N; Schiffer CA
    J Chem Theory Comput; 2019 Jan; 15(1):637-647. PubMed ID: 30457868
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structural determinants of APOBEC3B non-catalytic domain for molecular assembly and catalytic regulation.
    Xiao X; Yang H; Arutiunian V; Fang Y; Besse G; Morimoto C; Zirkle B; Chen XS
    Nucleic Acids Res; 2017 Jul; 45(12):7494-7506. PubMed ID: 28575276
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protein kinase A inhibits tumor mutator APOBEC3B through phosphorylation.
    Matsumoto T; Shirakawa K; Yokoyama M; Fukuda H; Sarca AD; Koyabu S; Yamazaki H; Kazuma Y; Matsui H; Maruyama W; Nagata K; Tanabe F; Kobayashi M; Shindo K; Morishita R; Sato H; Takaori-Kondo A
    Sci Rep; 2019 Jun; 9(1):8307. PubMed ID: 31165764
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structural Characterization of a Minimal Antibody against Human APOBEC3B.
    Tang H; Demir Ö; Kurniawan F; Brown WL; Shi K; Moeller NH; Carpenter MA; Belica C; Orellana K; Du G; LeBeau AM; Amaro RE; Harris RS; Aihara H
    Viruses; 2021 Apr; 13(4):. PubMed ID: 33921405
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The DNA deaminase APOBEC3B interacts with the cell-cycle protein CDK4 and disrupts CDK4-mediated nuclear import of Cyclin D1.
    McCann JL; Klein MM; Leland EM; Law EK; Brown WL; Salamango DJ; Harris RS
    J Biol Chem; 2019 Aug; 294(32):12099-12111. PubMed ID: 31217276
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nuclear Magnetic Resonance Structure of the APOBEC3B Catalytic Domain: Structural Basis for Substrate Binding and DNA Deaminase Activity.
    Byeon IJ; Byeon CH; Wu T; Mitra M; Singer D; Levin JG; Gronenborn AM
    Biochemistry; 2016 May; 55(21):2944-59. PubMed ID: 27163633
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Observation by Real-Time NMR and Interpretation of Length- and Location-Dependent Deamination Activity of APOBEC3B.
    Wan L; Nagata T; Morishita R; Takaori-Kondo A; Katahira M
    ACS Chem Biol; 2017 Nov; 12(11):2704-2708. PubMed ID: 28952713
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Small-Angle X-ray Scattering Models of APOBEC3B Catalytic Domain in a Complex with a Single-Stranded DNA Inhibitor.
    Barzak FM; Ryan TM; Kvach MV; Kurup HM; Aihara H; Harris RS; Filichev VV; Harjes E; Jameson GB
    Viruses; 2021 Feb; 13(2):. PubMed ID: 33673243
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of APOBEC3B Recognition Motifs by NMR Reveals Preferred Substrates.
    Liu M; Mallinger A; Tortorici M; Newbatt Y; Richards M; Mirza A; van Montfort RLM; Burke R; Blagg J; Kaserer T
    ACS Chem Biol; 2018 Sep; 13(9):2427-2432. PubMed ID: 30130388
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mutation Processes in 293-Based Clones Overexpressing the DNA Cytosine Deaminase APOBEC3B.
    Akre MK; Starrett GJ; Quist JS; Temiz NA; Carpenter MA; Tutt AN; Grigoriadis A; Harris RS
    PLoS One; 2016; 11(5):e0155391. PubMed ID: 27163364
    [TBL] [Abstract][Full Text] [Related]  

  • 12. APOBEC3B Nuclear Localization Requires Two Distinct N-Terminal Domain Surfaces.
    Salamango DJ; McCann JL; Demir Ö; Brown WL; Amaro RE; Harris RS
    J Mol Biol; 2018 Aug; 430(17):2695-2708. PubMed ID: 29787764
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enzyme cycling contributes to efficient induction of genome mutagenesis by the cytidine deaminase APOBEC3B.
    Adolph MB; Love RP; Feng Y; Chelico L
    Nucleic Acids Res; 2017 Nov; 45(20):11925-11940. PubMed ID: 28981865
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ILF2 enhances the DNA cytosine deaminase activity of tumor mutator APOBEC3B in multiple myeloma cells.
    Kazuma Y; Shirakawa K; Tashiro Y; Yamazaki H; Nomura R; Horisawa Y; Takeuchi S; Stanford E; Konishi Y; Matsui H; Matsumoto T; Tanabe F; Morishita R; Ito S; Takaori-Kondo A
    Sci Rep; 2022 Feb; 12(1):2278. PubMed ID: 35145187
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human APOBEC3B interacts with the heterogenous nuclear ribonucleoprotein A3 in cancer cells.
    Mishra N; Reddy KS; Timilsina U; Gaur D; Gaur R
    J Cell Biochem; 2018 Aug; 119(8):6695-6703. PubMed ID: 29693745
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular basis of the attenuated phenotype of human APOBEC3B DNA mutator enzyme.
    Caval V; Bouzidi MS; Suspène R; Laude H; Dumargne MC; Bashamboo A; Krey T; Vartanian JP; Wain-Hobson S
    Nucleic Acids Res; 2015 Oct; 43(19):9340-9. PubMed ID: 26384561
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of the mechanism by which the RB/E2F pathway controls expression of the cancer genomic DNA deaminase APOBEC3B.
    Roelofs PA; Goh CY; Chua BH; Jarvis MC; Stewart TA; McCann JL; McDougle RM; Carpenter MA; Martens JW; Span PN; Kappei D; Harris RS
    Elife; 2020 Sep; 9():. PubMed ID: 32985974
    [TBL] [Abstract][Full Text] [Related]  

  • 18. APOBEC3B promotes hepatocarcinogenesis and metastasis through novel deaminase-independent activity.
    Ma W; Ho DW; Sze KM; Tsui YM; Chan LK; Lee JM; Ng IO
    Mol Carcinog; 2019 May; 58(5):643-653. PubMed ID: 30575099
    [TBL] [Abstract][Full Text] [Related]  

  • 19. APOBEC3B cytidine deaminase targets the non-transcribed strand of tRNA genes in yeast.
    Saini N; Roberts SA; Sterling JF; Malc EP; Mieczkowski PA; Gordenin DA
    DNA Repair (Amst); 2017 May; 53():4-14. PubMed ID: 28351647
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Distinguishing preferences of human APOBEC3A and APOBEC3B for cytosines in hairpin loops, and reflection of these preferences in APOBEC-signature cancer genome mutations.
    Butt Y; Sakhtemani R; Mohamad-Ramshan R; Lawrence MS; Bhagwat AS
    Nat Commun; 2024 Mar; 15(1):2369. PubMed ID: 38499553
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.